Social Media Ideas for Phrma

Latest updates for Phrma

Fresh curated links around PhRMA are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Post angles to try

Share the most useful takeaway for your audience.

Turn one article into a quick practical checklist.

Ask your audience how this shift affects their work.

Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

pharmexec.com /3 weeks ago

<![CDATA[2026 Pharm Exec Top 50 Companies]]>

Read source

fiercehealthcare.com /1 week ago

PhRMA's Medicare price negotiation suit rebuffed in latest blow to industry IRA challenge

In the latest in a string of setbacks in biopharma’s efforts to fight Medicare drug price negotiations, a lawsuit from the industry’s top lobbying group has been rejected at the ap...

Read source

pharmexec.com /3 weeks ago

<![CDATA[2026 Emerging Pharma Leaders]]>

Read source

pharmexec.com /3 weeks ago

<![CDATA[Pharmaceutical Executive Daily: Pharm Exec Ranks Top 50 Companies of 2026]]>

Read source

pharmexec.com /3 weeks ago

<![CDATA[More Than Titles ]]>

Read source

pharmexec.com /4 weeks ago

<![CDATA[U.S. Rare Disease Biotech Investing Rises After FDA’s PRV Program Renewal: Report ]]>

Read source

pharmexec.com /1 month ago

<![CDATA[Pharmaceutical Executive Daily: BioMarin and n-Lorem Foundation Enter Collaboration]]>

Read source

pharmexec.com /1 week ago

<![CDATA[The Industry’s Shift on RWD]]>

Read source

pharmexec.com /1 month ago

<![CDATA[The New Pharma Visibility Journey]]>

Read source

pharmexec.com /5 days ago

<![CDATA[Your Questions Answered: The Biggest Pharma and Biotech Stories This Week]]>

Read source

pharmexec.com /3 weeks ago

<![CDATA[The Road Ahead: Advice for Pharma's Next Board Meeting]]>

Read source

pharmexec.com /1 month ago

<![CDATA[What FDA's Peptide Decision Means for the Industry]]>

Read source

pharmexec.com /1 month ago

<![CDATA[The Status of Nuvation Bio’s Pipeline]]>

Read source

pharmexec.com /1 month ago

<![CDATA[BioMarin and n-Lorem Foundation Enter Research Collaboration for ReNU Syndrome Treatment ]]>

Read source

pharmexec.com /3 weeks ago

<![CDATA[Finding the Universal Truth in a Drug's Story]]>

Read source

pharmexec.com /1 week ago

<![CDATA[Roundup: Alteogen Enters Option & License Agreement with Novartis, NewBiologix & Synastra Form BioTe...

Read source

pharmexec.com /2 weeks ago

<![CDATA[FDA Approves Pasatru For Adults With Fibrodysplasia Ossificans Progressiva ]]>

Read source

pharmexec.com /1 month ago

<![CDATA[FDA's New Frontier: Drug Pricing Enters the Conversation]]>

Read source

pharmexec.com /1 week ago

<![CDATA[Pharmaceutical Executive Daily: Nine Companies Strike Deals for MFN Pricing]]>

Read source

pharmexec.com /2 weeks ago

<![CDATA[What Executives and Investors Are Looking for in Pharma Companies]]>

Read source

pharmexec.com /1 month ago

<![CDATA[Pharmaceutical Executive Daily: FDA Votes 10 to 3 in Favor of Replimune's Rp1 Efficacy Data]]>

Read source

pharmexec.com /1 month ago

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Reytorpyk for Advanced Breast Cancer]]>

Read source

seekingalpha.com /1 month ago

SA Asks: What's the outlook for Big Pharma M&A?

Read source

pharmexec.com /4 weeks ago

<![CDATA[Taking a Hard Look at Pharma's Traditional Margin Model]]>

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Phrma

seekingalpha.com

Recent coverage from public sources

Public source

fiercehealthcare.com

Recent coverage from public sources

Public source

pharmexec.com

Recent coverage from public sources

Public source

Recent searches

Artificial Intelligence Machine Learning Data Science Data Engineering Business Intelligence Web Development Software Development Software Testing Programming JavaScript DevOps Cyber Security Product Management Project Management Design UX UX Research Graphic Design Video Production Video Editing

Latest updates for Phrma

Post angles to try

Fresh articles and ideas

&lt;![CDATA[2026 Pharm Exec Top 50 Companies]]&gt;

PhRMA's Medicare price negotiation suit rebuffed in latest blow to industry IRA challenge

&lt;![CDATA[2026 Emerging Pharma Leaders]]&gt;

&lt;![CDATA[Pharmaceutical Executive Daily: Pharm Exec Ranks Top 50 Companies of 2026]]&gt;

&lt;![CDATA[More Than Titles ]]&gt;

&lt;![CDATA[U.S. Rare Disease Biotech Investing Rises After FDA’s PRV Program Renewal: Report ]]&gt;

&lt;![CDATA[Pharmaceutical Executive Daily: BioMarin and n-Lorem Foundation Enter Collaboration]]&gt;

&lt;![CDATA[The Industry’s Shift on RWD]]&gt;

&lt;![CDATA[The New Pharma Visibility Journey]]&gt;

&lt;![CDATA[Your Questions Answered: The Biggest Pharma and Biotech Stories This Week]]&gt;

&lt;![CDATA[The Road Ahead: Advice for Pharma's Next Board Meeting]]&gt;

&lt;![CDATA[What FDA's Peptide Decision Means for the Industry]]&gt;

&lt;![CDATA[The Status of Nuvation Bio’s Pipeline]]&gt;

&lt;![CDATA[BioMarin and n-Lorem Foundation Enter Research Collaboration for ReNU Syndrome Treatment ]]&gt;

&lt;![CDATA[Finding the Universal Truth in a Drug's Story]]&gt;

&lt;![CDATA[Roundup: Alteogen Enters Option &amp; License Agreement with Novartis, NewBiologix &amp; Synastra Form BioTe...

&lt;![CDATA[FDA Approves Pasatru For Adults With Fibrodysplasia Ossificans Progressiva ]]&gt;

&lt;![CDATA[FDA's New Frontier: Drug Pricing Enters the Conversation]]&gt;

&lt;![CDATA[Pharmaceutical Executive Daily: Nine Companies Strike Deals for MFN Pricing]]&gt;

&lt;![CDATA[What Executives and Investors Are Looking for in Pharma Companies]]&gt;

&lt;![CDATA[Pharmaceutical Executive Daily: FDA Votes 10 to 3 in Favor of Replimune's Rp1 Efficacy Data]]&gt;

&lt;![CDATA[Pharmaceutical Executive Daily: FDA Approves Reytorpyk for Advanced Breast Cancer]]&gt;

SA Asks: What's the outlook for Big Pharma M&amp;A?

&lt;![CDATA[Taking a Hard Look at Pharma's Traditional Margin Model]]&gt;

Turn fresh research into a full content calendar

Sources covering Phrma

seekingalpha.com

fiercehealthcare.com

pharmexec.com

Related searches

Recent searches

<![CDATA[2026 Pharm Exec Top 50 Companies]]>

<![CDATA[2026 Emerging Pharma Leaders]]>

<![CDATA[Pharmaceutical Executive Daily: Pharm Exec Ranks Top 50 Companies of 2026]]>

<![CDATA[More Than Titles ]]>

<![CDATA[U.S. Rare Disease Biotech Investing Rises After FDA’s PRV Program Renewal: Report ]]>

<![CDATA[Pharmaceutical Executive Daily: BioMarin and n-Lorem Foundation Enter Collaboration]]>

<![CDATA[The Industry’s Shift on RWD]]>

<![CDATA[The New Pharma Visibility Journey]]>

<![CDATA[Your Questions Answered: The Biggest Pharma and Biotech Stories This Week]]>

<![CDATA[The Road Ahead: Advice for Pharma's Next Board Meeting]]>

<![CDATA[What FDA's Peptide Decision Means for the Industry]]>

<![CDATA[The Status of Nuvation Bio’s Pipeline]]>

<![CDATA[BioMarin and n-Lorem Foundation Enter Research Collaboration for ReNU Syndrome Treatment ]]>

<![CDATA[Finding the Universal Truth in a Drug's Story]]>

<![CDATA[Roundup: Alteogen Enters Option & License Agreement with Novartis, NewBiologix & Synastra Form BioTe...

<![CDATA[FDA Approves Pasatru For Adults With Fibrodysplasia Ossificans Progressiva ]]>

<![CDATA[FDA's New Frontier: Drug Pricing Enters the Conversation]]>

<![CDATA[Pharmaceutical Executive Daily: Nine Companies Strike Deals for MFN Pricing]]>

<![CDATA[What Executives and Investors Are Looking for in Pharma Companies]]>

<![CDATA[Pharmaceutical Executive Daily: FDA Votes 10 to 3 in Favor of Replimune's Rp1 Efficacy Data]]>

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Reytorpyk for Advanced Breast Cancer]]>

SA Asks: What's the outlook for Big Pharma M&A?

<![CDATA[Taking a Hard Look at Pharma's Traditional Margin Model]]>